Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome
Clinical trial NCT02452983 · TERMINATED
Trial details
- NCT number
- NCT02452983
- Sponsor
- Gustavo Rivero
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2020-11-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.